Terms: = Lymphoma AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Staging
16 results:
1. Long non-coding RNA small nucleolar RNA host gene 29 drives chronic myeloid leukemia progression via microRNA-483-3p/Casitas B-lineage lymphoma axis-mediated activation of the phosphoinositide 3-kinase/Akt pathway.
Feng X; Yang L; Liu X; Liu M; Liu L; Liu J; Luo J
Med Oncol; 2024 Jan; 41(2):60. PubMed ID: 38252204
[TBL] [Abstract] [Full Text] [Related]
2. TNF-α-308A allele Carrier Induced to Development of Chronic Lymphocytic Leukemia in Sudanese Population at Earlier Age.
Basabaeen AA; Abdelgader EA; Ahmed Babekir E; Abdelateif NM; Osman Abdelrahim S; Awadalkareem Omer AY; Altayeb OA; Fadul EA; Ibrahim IK
Asian Pac J Cancer Prev; 2022 Oct; 23(10):3449-3455. PubMed ID: 36308371
[TBL] [Abstract] [Full Text] [Related]
3. Interleukin-10-1082A>G (rs1800896) Single Nucleotide Polymorphism is Not a Risk Factor of Chronic Lymphocytic Leukemia in Sudanese Population.
Basabaeen AA; Abdelgader EA; Ahmed EB; Abdelateif NM; Osman Abdelrahim S; Sharif OM; Altayeb OA; Fadul EA; Osman Ibrahim I
Asian Pac J Cancer Prev; 2022 Sep; 23(9):3229-3235. PubMed ID: 36172689
[TBL] [Abstract] [Full Text] [Related]
4. Gamma-heavy chain disease.
Kušnierová P; Zeman D; Jelínek T; Hájek R
Klin Onkol; 2020; 33(4):282-285. PubMed ID: 32894957
[TBL] [Abstract] [Full Text] [Related]
5. [Clinicopathological features of myeloid sarcoma and DLBCL in the breast: a comparative study].
Chen DB; Zhang H; Kong FZ; Jiang Q; Fang XZ; Shen DH; Kan X
Zhonghua Bing Li Xue Za Zhi; 2020 Mar; 49(3):250-255. PubMed ID: 32187897
[No Abstract] [Full Text] [Related]
6.
Wu H; Liu C; Yang Q; Xin C; Du J; Sun F; Zhou L
Autophagy; 2020 Apr; 16(4):683-697. PubMed ID: 31242129
[TBL] [Abstract] [Full Text] [Related]
7. TP53 Gene 72 Arg/Pro (rs1042522) Single Nucleotide Polymorphism Contribute to Increase the Risk of B-Chronic Lymphocytic Leukemia in the Sudanese Population.
Mohammed Basabaeen AA; Abdelgader EA; Babekir EA; Abdelrahim SO; Eltayeb NH; Altayeb OA; Fadul EA; Sabo A; Ibrahim IK
Asian Pac J Cancer Prev; 2019 May; 20(5):1579-1585. PubMed ID: 31128065
[TBL] [Abstract] [Full Text] [Related]
8. [Abnormal Expression and Clinical Significance of B Lymphocyte Stimulating Factor in B Cell-derived Malignant Hematologic Diseases].
Han XL; Zhang XY; Li JD; Wang WL; Yang C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):138-141. PubMed ID: 28245390
[TBL] [Abstract] [Full Text] [Related]
9. Plasmablastic lymphoma of the oral cavity with breast recurrence: a case report.
Samoon Z; Idrees R; Masood N; Ansari TZ
BMC Res Notes; 2015 May; 8():180. PubMed ID: 25933603
[TBL] [Abstract] [Full Text] [Related]
10. Hodgkin's lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis.
Gasljevic G; Grcar-Kuzmanov B; Grosel A; Sever M; Gazic B; Kloboves-Prevodnik V
Diagn Pathol; 2015 Mar; 10():5. PubMed ID: 25881198
[TBL] [Abstract] [Full Text] [Related]
11. Primary malignant melanoma of the breast: case report and review of the literature.
Drueppel D; Schultheis B; Solass W; Ergonenc H; Tempfer CB
Anticancer Res; 2015 Mar; 35(3):1709-13. PubMed ID: 25750332
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical and laboratory features of four cases with IgM multiple myeloma].
Fan JL; Fu WJ; Shi HT; Zhou F; Yuan ZG; Zhang CY; Wei W; Ye F; Zhang H; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):341-4. PubMed ID: 23668209
[TBL] [Abstract] [Full Text] [Related]
13. [Current options and principles of pathomorphology-based tumour diagnostics].
Povýsil C
Vnitr Lek; 2010 Jul; 56(7):709-14. PubMed ID: 20842917
[TBL] [Abstract] [Full Text] [Related]
14. Plasma heparanase as a significant marker of treatment response in children with Hodgkin lymphoma: pilot study.
Ben Arush MW; Shafat I; Ben Barak A; Shalom RB; Vlodavsky I; Ilan N
Pediatr Hematol Oncol; 2009 Jun; 26(4):157-64. PubMed ID: 19437318
[TBL] [Abstract] [Full Text] [Related]
15. A comparative study of the quality of DNA obtained from fresh frozen and formalin-fixed decalcified paraffin-embedded bone marrow trephine biopsy specimens using two different methods.
Talaulikar D; Gray JX; Shadbolt B; McNiven M; Dahlstrom JE
J Clin Pathol; 2008 Jan; 61(1):119-23. PubMed ID: 17545562
[TBL] [Abstract] [Full Text] [Related]
16. Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting.
Braylan RC; Orfao A; Borowitz MJ; Davis BH
Cytometry; 2001 Feb; 46(1):23-7. PubMed ID: 11241503
[TBL] [Abstract] [Full Text] [Related]
